Drug Trial Radar · NCT03747458
OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps
Last checked: Nov 19, 2026Latest source record: Sep 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Dec 31, 2018
Primary completion
Mar 31, 2026
Study completion Jun 11, 2026
Sponsor
- Lead sponsor
- Optinose US Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Paratek Pharmaceuticals Inc
- First posted
- Nov 20, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 16-Week Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety of OPN-375 186 μg Twice a Day (BID) in Adolescents with Bilateral Nasal Polyps followed by a 12-Week Open-Label Treatment Phase. The total planned number of subjects is approximately 72 adolescents (12-17 years of age) who will be randomly assigned to receive 1 of 2 study treatments using a 2:1 ratio (OPN-375 186 μg: Placebo). For the PK sub-study, up to 14 subjects will be enrolled to obtain 10 completers.
Conditions
- Bilateral Nasal Polyposis
Interventions
OPN-375Drug
OPN-375, BID
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in nasal congestion/obstruction symptoms (mild, moderate, severe) at the end of Week 4Time frame: 4 Weeks
- Mean change from baseline at Week 16 in total polyp gradeTime frame: 16 Weeks
Locations
31 sites in 2 countries. Site status is shown where the registry gives one.
San Tan Allergy & Asthma
Gilbert, Arizona
Kern Research
Bakersfield, California
Central California Clinical Research
Fresno, California
Sensa Health
Los Angeles, California
Children's Hospital of Los Angeles
Los Angeles, California
Children's Hospital of Orange County
Orange, California
Allergy and Asthma Consultants
Redwood City, California
Sacramento ENT
Roseville, California
Rady Children's Hospital San Diego
San Diego, California
Children's Hospital Colorado
Aurora, Colorado
Children's Healthcare of Atlanta
Atlanta, Georgia
Chicago ENT
Chicago, Illinois
Kentuckiana ENT
Louisville, Kentucky
University of Rochester
Rochester, New York
Allergy Asthma & Immunology Research Institute
Charlotte, North Carolina
Allergy, Asthma & Clinical Research Center
Oklahoma City, Oklahoma
Vital Prospects Clinical Research Institute, P.C.
Tulsa, Oklahoma
Carolina ENT
Orangeburg, South Carolina
STAAMP Research
San Antonio, Texas
University of Utah
Salt Lake City, Utah
Eastern Virginia Medical School - Otolaryngology
Norfolk, Virginia
Spokane ENT
Spokane Valley, Washington
Sanatorio Guemes
Buenos Aires, Argentina
Fundacion CIDEA
Buenos Aires, Argentina
InAER - Investigaciones en Alergia y Enfermedades Respiratorias
Buenos Aires, Argentina
Instituto de Asma Alergia y Enfermedades Respiratoria (IAAER)
Corrientes, Argentina
Centro Medico INSARES
Mendoza, Argentina
Instituto Medico Rio Cuarto
Río Cuarto, Córdoba Province, Argentina
Instituto Medico de la Fundacion de Estudios Clinicos - Consultorios Integrados Rosario
Rosario, Santa Fe Province, Argentina
Centro de Investigaciones Clinicas - Instituto de la Salud Rosario
Rosario, Santa Fe Province, Argentina
Clinica Mayo, UMCB
San Miguel de Tucumán, Tucumán Province, Argentina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.